低收入和中低收入国家视网膜母细胞瘤的动脉内化疗 - - Suppr

Suppr

超能文献

Intraarterial chemotherapy for retinoblastoma in low and lower-middle-income countries -

作者信息

Honavar Santosh G

机构信息

Editor, Indian Journal of Ophthalmology, Centre for Sight, Banjara Hills, Hyderabad, Telangana, India.

出版信息

Indian J Ophthalmol. 2023 Feb;71(2):325-326. doi: 10.4103/IJO.IJO_227_23.

DOI:10.4103/IJO.IJO_227_23

PMID:36727311

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10228966/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb3c/10228966/5c5697df826c/IJO-71-325-g001.jpg

相似文献

Intraarterial chemotherapy for retinoblastoma in low and lower-middle-income countries -低收入和中低收入国家视网膜母细胞瘤的动脉内化疗 -

Indian J Ophthalmol. 2023 Feb;71(2):325-326. doi: 10.4103/IJO.IJO_227_23.

[Superselective intra-arterial chemotherapy with melphalan for retinoblastoma].[美法仑超选择性动脉内化疗治疗视网膜母细胞瘤]

J Fr Ophtalmol. 2014 Feb;37(2):176. doi: 10.1016/j.jfo.2013.05.021. Epub 2013 Nov 7.

Orbital Swelling in a Child With Retinoblastoma Following Intra-arterial Chemotherapy.动脉内化疗后视网膜母细胞瘤患儿的眼眶肿胀

JAMA Ophthalmol. 2021 Mar 1;139(3):357-358. doi: 10.1001/jamaophthalmol.2020.4675.

Real-time ophthalmoscopic findings of intraophthalmic artery chemotherapy in retinoblastoma.视网膜母细胞瘤眼内动脉化疗的实时检眼镜检查结果

Arch Ophthalmol. 2012 Aug;130(8):1075-7. doi: 10.1001/archophthalmol.2012.180.

Supraselective injection of intraarterial melphalan as the primary treatment for late presentation unilateral multifocal stage Vb retinoblastoma.超选择动脉内注射氨甲蝶呤作为晚期单侧多灶性 Vb 期视网膜母细胞瘤的主要治疗方法。

Retina. 2010 Apr;30(4 Suppl):S63-5. doi: 10.1097/IAE.0b013e3181cbda0f.

Intravitreal HDAC Inhibitor Belinostat Effectively Eradicates Vitreous Seeds Without Retinal Toxicity In Vivo in a Rabbit Retinoblastoma Model.玻璃体内注射组蛋白去乙酰化酶抑制剂贝利司他可有效根除兔视网膜母细胞瘤模型体内的玻璃体细胞，且无视网膜毒性。

Invest Ophthalmol Vis Sci. 2021 Nov 1;62(14):8. doi: 10.1167/iovs.62.14.8.

Histopathology of retinoblastoma eyes enucleated after intra-arterial chemotherapy.经动脉化疗后摘除的视网膜母细胞瘤眼的组织病理学。

Br J Ophthalmol. 2020 Aug;104(8):1171-1175. doi: 10.1136/bjophthalmol-2019-315209. Epub 2019 Nov 1.

INTRAARTERIAL CHEMOTHERAPY FOR RETINOBLASTOMA IN A 2-MONTH-OLD INFANT.2个月婴儿视网膜母细胞瘤的动脉内化疗

Retin Cases Brief Rep. 2017;11(1):24-26. doi: 10.1097/ICB.0000000000000279.

Pars plana vitrectomy under melphalan irrigation for recurrent retinal detachment in eyes treated for retinoblastoma: a case report.丝裂霉素 C 灌洗下平坦部玻璃体切除术治疗视网膜母细胞瘤治疗眼复发性视网膜脱离: 1 例报告。

BMC Ophthalmol. 2020 Jan 28;20(1):34. doi: 10.1186/s12886-020-1315-7.

Alternative treatment for retinoblastoma: Intra-arterial chemotherapy with melphalan.视网膜母细胞瘤的替代治疗：美法仑动脉内化疗。

Arch Soc Esp Oftalmol. 2015 Oct;90(10):487-90. doi: 10.1016/j.oftal.2015.04.004. Epub 2015 May 23.

引用本文的文献

Suprachoroidal Injection of Topotecan for Retinoblastoma: A Preclinical Study.脉络膜上腔注射拓扑替康治疗视网膜母细胞瘤的临床前研究

Ophthalmol Sci. 2025 Jul 4;5(6):100875. doi: 10.1016/j.xops.2025.100875. eCollection 2025 Nov-Dec.

Pediatric cancers and family financial toxicity in the Philippines: insights for Southeast Asia and similarly resourced settings.菲律宾的儿童癌症与家庭经济毒性：对东南亚及资源类似地区的启示

Lancet Reg Health West Pac. 2024 Jun 28;47:101114. doi: 10.1016/j.lanwpc.2024.101114. eCollection 2024 Jun.

本文引用的文献

Intra-arterial chemotherapy in refractory and advanced intraocular retinoblastoma.动脉内化疗治疗难治性和晚期眼内视网膜母细胞瘤。

Indian J Ophthalmol. 2023 Feb;71(2):436-443. doi: 10.4103/ijo.IJO_1388_22.

The Global Retinoblastoma Outcome Study: a prospective, cluster-based analysis of 4064 patients from 149 countries.《全球视网膜母细胞瘤结局研究：一项针对来自 149 个国家的 4064 名患者的前瞻性、基于群组的分析》。

Lancet Glob Health. 2022 Aug;10(8):e1128-e1140. doi: 10.1016/S2214-109X(22)00250-9.

Global retinoblastoma survival and globe preservation: a systematic review and meta-analysis of associations with socioeconomic and health-care factors.全球视网膜母细胞瘤的生存率和眼球保留率：与社会经济和医疗保健因素关联的系统评价和荟萃分析。

Lancet Glob Health. 2022 Mar;10(3):e380-e389. doi: 10.1016/S2214-109X(21)00555-6. Epub 2022 Jan 27.

Access to care for childhood cancers in India: perspectives of health care providers and the implications for universal health coverage.印度儿童癌症的医疗服务可及性：卫生保健提供者的观点及其对全民健康覆盖的影响。

BMC Public Health. 2020 Nov 3;20(1):1641. doi: 10.1186/s12889-020-09758-3.

Economic burden for retinoblastoma patients in China.中国视网膜母细胞瘤患者的经济负担。

J Med Econ. 2020 Dec;23(12):1553-1557. doi: 10.1080/13696998.2020.1831518. Epub 2020 Oct 27.

Intra-arterial chemotherapy in retinoblastoma - A paradigm change.眼内动脉化疗治疗视网膜母细胞瘤——一种范式转变。

Indian J Ophthalmol. 2019 Jun;67(6):740-754. doi: 10.4103/ijo.IJO_866_19.

Childhood cancer burden: a review of global estimates.儿童癌症负担：全球估计的综述。

Lancet Oncol. 2019 Jan;20(1):e42-e53. doi: 10.1016/S1470-2045(18)30761-7.

Retinoblastoma.视网膜母细胞瘤。

Indian J Pediatr. 2017 Dec;84(12):937-944. doi: 10.1007/s12098-017-2395-0. Epub 2017 Jun 16.

Retinoblastoma treatment burden and economic cost: impact of age at diagnosis and selection of primary therapy.视网膜母细胞瘤的治疗负担与经济成本：诊断年龄及初始治疗选择的影响

Clin Ophthalmol. 2012;6:1601-6. doi: 10.2147/OPTH.S33094. Epub 2012 Oct 4.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验